The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Jolanta Małyszko

Department of Nephrology and Transplantology

Medical University

Bialystok

Poland. Electronic address:

[email]@*.onet.pl

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Nephrology and Transplantology, Medical University, Bialystok, Poland. Electronic address:. 2002 - 2012

References

  1. Treatment of anemia with erythropoietin-stimulating agents in kidney transplant recipients and chronic kidney disease-another drawback of immunosuppression? Malyszko, J., Glowinska, I., Mysliwiec, M. Transplant. Proc. (2012) [Pubmed]
  2. Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients? Malyszko, J., Malyszko, J.S., Levin-Iaina, N., Koc-Zorawska, E., Kozminski, P., Mysliwiec, M. Int. Urol. Nephrol (2011) [Pubmed]
  3. Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients. Malyszko, J., Kozminski, P., Malyszko, J., Mysliwiec, M. Int. Urol. Nephrol (2011) [Pubmed]
  4. Visfatin and endothelial function in dialyzed patients. Malyszko, J., Malyszko, J.S., Mysliwiec, M. Nephrology. (Carlton) (2010) [Pubmed]
  5. Neutrophil gelatinase-associated lipocalin and hepcidin: what do they have in common and is there a potential interaction? Malyszko, J., Tesar, V., Macdougall, I.C. Kidney Blood Press. Res. (2010) [Pubmed]
  6. Prevalence of chronic kidney disease in orthotopic heart transplant recipients and kidney allograft recipients using the new Chronic Kidney Disease Epidemiology Collaboration formula. Malyszko, J., Przybylowski, P., Malyszko, J.S., Iaina-Levin, N., Sadowski, J., Mysliwiec, M. Transplant. Proc. (2010) [Pubmed]
  7. Mechanism of endothelial dysfunction in chronic kidney disease. Malyszko, J. Clin. Chim. Acta (2010) [Pubmed]
  8. Kidney injury molecule-1 correlates with kidney function in renal allograft recipients. Malyszko, J., Koc-Zorawska, E., Malyszko, J.S., Mysliwiec, M. Transplant. Proc. (2010) [Pubmed]
  9. Prevalence of chronic kidney disease and anemia in patients with coronary artery disease with normal serum creatinine undergoing percutaneous coronary interventions: relation to New York Heart Association class. Malyszko, J., Bachorzewska-Gajewska, H., Malyszko, J., Levin-Iaina, N., Iaina, A., Dobrzycki, S. Isr. Med. Assoc. J. (2010) [Pubmed]
  10. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Malyszko, J., Malyszko, J.S., Bachorzewska-Gajewska, H., Poniatowski, B., Dobrzycki, S., Mysliwiec, M. Transplant. Proc. (2009) [Pubmed]
  11. Visfatin, a new adipocytokine, is predominantly related to inflammation/endothelial damage in kidney allograft recipients. Malyszko, J., Malyszko, J.S., Mysliwiec, M. Transplant. Proc. (2009) [Pubmed]
  12. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Malyszko, J., Bachorzewska-Gajewska, H., Poniatowski, B., Malyszko, J.S., Dobrzycki, S. Ren. Fail (2009) [Pubmed]
  13. Hemojuvelin: the hepcidin story continues. Malyszko, J. Kidney Blood Press. Res. (2009) [Pubmed]
  14. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy. Malyszko, J., Malyszko, J.S., Mysliwiec, M. Kidney Blood Press. Res. (2009) [Pubmed]
  15. Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients: potential role of prohepcidin, hepcidin, and inflammation. Malyszko, J., Malyszko, J.S., Mysliwiec, M. Ren. Fail (2009) [Pubmed]
  16. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin. Malyszko, J., Malyszko, J.S., Kozminski, P., Mysliwiec, M. Ren. Fail (2009) [Pubmed]
  17. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients. Malyszko, J., Malyszko, J.S., Mysliwiec, M. Clin. Transplant (2009) [Pubmed]
  18. Structural changes in carotid arteries and impairment of fibrinolysis in hemodialyzed and peritoneally dialyzed patients. Małyszko, J., Łebkowska, U., Małyszko, J.S., Myśliwiec, M. Med. Sci. Monit. (2009) [Pubmed]
  19. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation. Malyszko, J., Malyszko, J.S., Koc-Zorawska, E., Kozminski, P., Mysliwiec, M. Kidney Blood Press. Res. (2009) [Pubmed]
  20. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications. Małyszko, J., Małyszko, J., Bachórzewska-Gajewska, H., Poniatowski, B., Dobrzycki, S., Mysliwiec, M. Transplant. Proc. (2009) [Pubmed]
  21. A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients. Malyszko, J., Malyszko, J.S., Mysliwiec, M. Transplant. Proc. (2009) [Pubmed]
  22. Kidney dysfunction after non renal solid organ transplantation. Malyszko, J., Durlik, M., Przybylowski, P. Ann. Transplant. (2009) [Pubmed]
  23. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Malyszko, J., Bachorzewska-Gajewska, H., Sitniewska, E., Malyszko, J.S., Poniatowski, B., Dobrzycki, S. Ren. Fail (2008) [Pubmed]
  24. Adipokines, linking adipocytes and vascular function in hemodialyzed patients, may also be possibly related to CD146, a novel adhesion molecule. Malyszko, J., Malyszko, J.S., Kozminski, P., Pawlak, K., Mysliwiec, M. Clin. Appl. Thromb. Hemost. (2008) [Pubmed]
  25. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease. Malyszko, J., Bachorzewska-Gajewska, H., Malyszko, J.S., Pawlak, K., Dobrzycki, S. Nephrology. (Carlton) (2008) [Pubmed]
  26. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure. Malyszko, J., Malyszko, J.S., Pawlak, K., Mysliwiec, M. Adv. Med. Sci (2008) [Pubmed]
  27. Endothelial function and novel adhesion molecule CD44 in kidney allograft recipients. Malyszko, J., Malyszko, J.S., Pawlak, K., Mysliwiec, M. Transplant. Proc. (2008) [Pubmed]
  28. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients. Malyszko, J., Malyszko, J.S., Pawlak, K., Wolczynski, S., Mysliwiec, M. Transplant. Proc. (2008) [Pubmed]
  29. Hepcidin is linked to anemia and inflammation in peritoneal dialysis patients. Malyszko, J., Malyszko, J.S., Pawlak, K., Drozdowska-Rams, L., Brzosko, S., Mysliwiec, M. Perit. Dial. Int (2008) [Pubmed]
  30. Markers of bone metabolism in hemodialyses and hemodiafiltration. Małyszko, J., Małyszko, J.S., Koźminski, P., Pawlak, K., Wołczynski, S., Myśliwiec, M. Ren. Fail (2007) [Pubmed]
  31. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients. Malyszko, J., Malyszko, J.S., Kozminski, P., Pawlak, K., Mysliwiec, M. Nephrology. (Carlton) (2007) [Pubmed]
  32. Thyroid function, endothelium, and inflammation in hemodialyzed patients: possible relations?. Malyszko, J., Malyszko, J.S., Pawlak, K., Mysliwiec, M. J. Ren. Nutr (2007) [Pubmed]
  33. Hepcidin in anemia and inflammation in chronic kidney disease. Malyszko, J., Mysliwiec, M. Kidney Blood Press. Res. (2007) [Pubmed]
  34. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients. Małyszko, J., Małyszko, J.S., Pawlak, K., Wołczyński, S., Myśliwiec, M. Adv. Med. Sci (2006) [Pubmed]
  35. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?. Malyszko, J., Malyszko, J., Wolczynski, S., Mysliwiec, M. Nephrol. Dial. Transplant. (2006) [Pubmed]
  36. Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients. Malyszko, J., Malyszko, J.S., Hryszko, T., Mysliwiec, M. Transplant. Proc. (2006) [Pubmed]
  37. Apelin and cardiac function in hemodialyzed patients: possible relations?. Małyszko, J., Małyszko, J.S., Koźminski, P., Myśliwiec, M. Am. J. Nephrol. (2006) [Pubmed]
  38. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Malyszko, J., Malyszko, J.S., Pawlak, K., Mysliwiec, M. Am. J. Hematol. (2006) [Pubmed]
  39. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease. Malyszko, J., Malyszko, J.S., Pawlak, K., Mysliwiec, M. Transplant. Proc. (2006) [Pubmed]
  40. Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Malyszko, J., Malyszko, J.S., Pawlak, K., Mysliwiec, M. Transplant. Proc. (2006) [Pubmed]
  41. Possible relations between thyroid function, endothelium, and kidney and liver function in kidney allograft recipients. Malyszko, J., Malyszko, J.S., Pawlak, K., Mysliwiec, M. Transplant. Proc. (2006) [Pubmed]
  42. Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?. Małyszko, J., Małyszko, J.S., Myśliwiec, M. Thromb. Res. (2005) [Pubmed]
  43. Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients. Małyszko, J., Małyszko, J.S., Brzosko, S., Wołczynski, S., Myśliwiec, M. Am. J. Nephrol. (2005) [Pubmed]
  44. Cardiovascular risk in chronic renal disease and transplantation prevention and management. Malyszko, J., Malyszko, J.S., Bachorzewska-Gajewska, H. Expert. Opin. Pharmacother (2005) [Pubmed]
  45. Correlations between leptin, body composition, bone mineral density, and bone metabolism in kidney transplant recipients. Malyszko, J., Malyszko, J.S., Pawlak, K., Konstantynowicz, J., Wolczynski, S., Kaczmarski, M., Mysliwiec, M. Transplant. Proc. (2005) [Pubmed]
  46. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis. Małyszko, J., Małyszko, J.S., Myśliwiec, M. Kidney Blood Press. Res. (2004) [Pubmed]
  47. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy. Małyszko, J., Małyszko, J.S., Hryszko, T., Myśliwiec, M. Thromb. Haemost. (2004) [Pubmed]
  48. Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients. Malyszko, J., Malyszko, J.S., Hryszko, T., Mysliwiec, M. Blood Coagul. Fibrinolysis (2004) [Pubmed]
  49. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. Malyszko, J., Malyszko, J.S., Brzosko, S., Wolczynski, S., Mysliwiec, M. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  50. Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients. Małyszko, J., Małyszko, J.S., Hryszko, T., Pawlak, K., Myśliwiec, M. Am. J. Nephrol. (2004) [Pubmed]
  51. Bone mineral density and bone metabolism are not related to leptin in hemodialyzed and peritoneally dialyzed uremic patients. Małyszko, J., Małyszko, J.S., Bondyra, Z., Wołczyński, S., Łebkowska, U., Myśliwiec, M. Med. Sci. Monit. (2004) [Pubmed]
  52. Correlations of new markers of bone formation and resorption in kidney transplant recipients. Małyszko, J., Wołczyński, S., Małyszko, J.S., Konstantynowicz, J., Kaczmarski, M., Myśliwiec, M. Transplant. Proc. (2003) [Pubmed]
  53. Influence of simvastatin on aspects of thrombogenesis in CAPD patients. Malyszko, J., Malyszko, J.S., Hryszko, T., Mysliwiec, M. Perit. Dial. Int (2003) [Pubmed]
  54. Some aspects of hemostasis in kidney transplant recipients maintained on cyclosporine, azathioprine, and prednisone in comparison to patients treated with cyclosporine and prednisone. Malyszko, J., Malyszko, J.S., Hryszko, T., Mysliwiec, M. Transplant. Proc. (2003) [Pubmed]
  55. Effects of fluvastatin on homocysteine and serum lipids in kidney allograft recipients. Małyszko, J., Małyszko, J.S., Brzósko, S., Pawlak, K., Myśliwiec, M. Ann. Transplant. (2002) [Pubmed]
  56. Effects of immunosuppressive drugs on platelet aggregation in vitro. Małyszko, J., Małyszko, J.S., Takada, A., Myśliwiec, M. Ann. Transplant. (2002) [Pubmed]
  57. Leptin correlates with some hemostatic parameters in CAPD patients. Małyszko, J., Wołczyński, S., Małyszko, J., Myśliwiec, M. Nephron (2002) [Pubmed]
  58. Vitamin K status in relation to bone metabolism in patients with renal failure. Małyszko, J., Wołczyński, S., Skrzydlewska, E., Małyszko, J.S., Myśliwiec, M. Am. J. Nephrol. (2002) [Pubmed]
  59. Some aspects of hemostasis in CAPD patients treated with erythropoietin. Małyszko, J., Suchowierska, E., Małyszko, J.S., Myśliwiec, M. Kidney Blood Press. Res. (2002) [Pubmed]
  60. Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome. Malyszko, J., Malyszko, J.S., Mysliwiec, M. Blood Coagul. Fibrinolysis (2002) [Pubmed]
  61. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin. Malyszko, J., Suchowierska, E., Malyszko, J.S., Mysliwiec, M. Perit. Dial. Int (2002) [Pubmed]
  62. Parvovirus B19 infection and IGF system components in relation to erythropoiesis in dialyzed patients and kidney transplant recipients. Malyszko, J., Hryszko, T., Malyszko, J.S., Wolczyński, S., Myśliwiec, M. Transplant. Proc. (2002) [Pubmed]
  63. Simvastatin and markers of endothelial function in patients undergoing continuous ambulatory peritoneal dialysis. Malyszko, J., Malyszko, J.S., Hryszko, T., Brzosko, S., Mysliwiec, M. Int. J. Tissue. React (2002) [Pubmed]
 
WikiGenes - Universities